Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors
- PMID: 3130492
- PMCID: PMC253265
- DOI: 10.1128/JVI.62.6.1849-1854.1988
Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors
Abstract
Mycophenolic acid, an inhibitor of purine metabolism, was shown to block the replication of vaccinia virus in normal cell lines. This observation led to the development of a dominant one-step plaque selection system, based on expression of the Escherichia coli gpt gene, for the isolation of recombinant vaccinia viruses. Synthesis of xanthine-guanine phosphoribosyltransferase enabled only the recombinant viruses to form large plaques in a selective medium containing mycophenolic acid, xanthine, and hypoxanthine. To utilize the selection system efficiently, we constructed a series of plasmids that contain the E. coli gpt gene and allow insertion of foreign genes into multiple unique restriction endonuclease sites in all three reading frames between the translation initiation codon of a strong late promoter and synthetic translation termination sequences. The selection-expression cassette is flanked by vaccinia virus DNA that directs homologous recombination into the virus genome. The new vectors allow high-level expression of complete or partial open reading frames and rapid construction of recombinant viruses by facilitating the cloning steps and by simplifying their isolation. The system was tested by cloning the E. coli beta-galactosidase gene; in 24 h, this enzyme accounted for approximately 3.5% of the total infected-cell protein.
Similar articles
-
A dominant selectable marker for the construction of recombinant poxviruses.Gene. 1988 May 15;65(1):123-8. doi: 10.1016/0378-1119(88)90424-6. Gene. 1988. PMID: 2840353
-
Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression.Gene. 1986;47(2-3):193-9. doi: 10.1016/0378-1119(86)90063-6. Gene. 1986. PMID: 3104141
-
Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.J Virol. 1989 Sep;63(9):3829-36. doi: 10.1128/JVI.63.9.3829-3836.1989. J Virol. 1989. PMID: 2547999 Free PMC article.
-
Construction and isolation of recombinant vaccinia virus using genetic markers.Methods Mol Biol. 2004;269:15-30. doi: 10.1385/1-59259-789-0:015. Methods Mol Biol. 2004. PMID: 15114004 Review.
-
Transient and inducible expression of vaccinia/T7 recombinant viruses.Methods Mol Biol. 2004;269:41-50. doi: 10.1385/1-59259-789-0:041. Methods Mol Biol. 2004. PMID: 15114006 Review.
Cited by
-
Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences.Gene. 1991 Dec 15;108(2):201-9. doi: 10.1016/0378-1119(91)90435-e. Gene. 1991. PMID: 1660838 Free PMC article.
-
Virosomes as new carrier system for cancer vaccines.Cancer Immunol Immunother. 2004 Nov;53(11):1005-17. doi: 10.1007/s00262-004-0545-5. Epub 2004 Jun 5. Cancer Immunol Immunother. 2004. PMID: 15185010 Free PMC article.
-
Template-dependent initiation of Sindbis virus RNA replication in vitro.J Virol. 1998 Aug;72(8):6546-53. doi: 10.1128/JVI.72.8.6546-6553.1998. J Virol. 1998. PMID: 9658098 Free PMC article.
-
Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro.J Virol. 1993 Jun;67(6):3384-95. doi: 10.1128/JVI.67.6.3384-3395.1993. J Virol. 1993. PMID: 8497057 Free PMC article.
-
Expression and identification of hepatitis C virus polyprotein cleavage products.J Virol. 1993 Mar;67(3):1385-95. doi: 10.1128/JVI.67.3.1385-1395.1993. J Virol. 1993. PMID: 7679746 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources